Oral hypoglycemic agents: the pharmacological basis of their clinical use
Davidoff, F.
Rhode Island Medical Journal 56(10): 409-414
1973
ISSN/ISBN: 0035-4627 PMID: 4518221 Document Number: 68507
Document emailed within 1 workday
Related Documents
Hazard, J. 1976: Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use La Nouvelle Presse Medicale 5(14): 903-905Vázquez, A.; Moya, G.; Ricoy, J.R. 1970: Neurological aspects of hypoglycemic coma; hypoglycemic comas of medical origin caused by hypoglycemic agents Revista Clinica Espanola 117(2): 157-168
Qian, R. 1997: Proper use of oral hypoglycemic agents Zhonghua Nei Ke Za Zhi 36(3): 149-150
Skillman, T.G. 1973: Present status of the oral hypoglycemic agents South Dakota Journal of Medicine 26(2): 25-29
Otto-Buczkowska, E. 1973: Use of oral hypoglycemic agents in diabetic children Polski Tygodnik Lekarski 28(24): 904-907
Grujić, M.; Perinović, M.; Rizvanbegović, B. 1976: Oral therapy of diabetes mellitus by combination of hypoglycemic agents Medicinski Arhiv 30(3): 167-171
Kunoh, Y.; Ogawa, H.; Nagasaka, M.; Asai, H.; Iguchi, A.; Niki, A.; Sakamoto, N. 1989: Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 298: 276-287
Pollock, S.H.; Reichbaum, M.I.; Collier, B.H.; D'Souza, M.J. 1991: Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats Journal of Pharmacology and Experimental Therapeutics 258(1): 8-12
Tattersall, R.B. 1984: 25 years of diabetic treatment by oral hypoglycemic agents: successes and failures Journees annuelles de diabetologie de l'Hotel-Dieu 1984: 183-191
Muller, A.J. 1972: Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents Journal of the American Osteopathic Association 71(12): 1093-1097
Katsuno, T.; Miyagawa, J.-I. 2012: Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 693-698
Aftab, M.T.; Dharamshi, H.A.; Faraz, A.; Shakeel, S.; Shakeel, O. 2017: Poor adherence with ACE inhibitors is a risk factor of CVA with oral hypoglycemic agents in diabetic patients Pakistan Journal of Pharmaceutical Sciences 30(2): 415-419
Chuang, L.M.; Lu, C.; Su, R.J.; Wu, H.P.; Tai, T.Y.; Lin, B.J. 1992: Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents Journal of the Formosan Medical Association 91(2): 185-189
Colman, P.G.; Harrison, L.C.; Tait, B.D. 1985: Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents Australian and New Zealand Journal of Medicine 15(2): 209-212
Vu, T.Quoc. 2019: Hypoglyceamia cases in diabetic patients with insulin and oral hypoglycemic agents: A retrospective research in a secondary health facility Jpma. Journal of the Pakistan Medical Association 69(Suppl. 2)(6): S75-S79
Accettella, U.; Sacra, A.; Gentile, M. 1970: Hypoglycemic attacks caused by oral hypoglycemic drugs Il Policlinico. Sezione Pratica 77(37): 1173-1178
Ruiz, F.; Durruty, P.; López, G.; García de los Ríos, M. 1981: Insulin levels in non-insulin dependent diabetics with secondary failure to oral hypoglycemic agents Revista Medica de Chile 109(9): 821-824
Wessler, S.; Gitel, S.N.; Wan, L.S.; Pasternack, B.S. 1976: Estrogen-containing oral contraceptive agents. a basis for their thrombogenicity JAMA 236(19): 2179-2182
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Lentini, S.; Bossini, A.; Pirola, L.C. 1972: A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024) Arzneimittel-Forschung 22(7): 1169-1173